Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;84(6):834-872.
doi: 10.1016/j.jinf.2022.03.014. Epub 2022 Mar 17.

Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants

Chloé Dimeglio  1 , Jean-Michel Loubes  2 , Marion Migueres  3 , Karine Sauné  3 , Pauline Trémeaux  3 , Sébastien Lhomme  3 , Noémie Ranger  4 , Justine Latour  4 , Jean-Michel Mansuy  4 , Jacques Izopet  3
Affiliations

Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants

Chloé Dimeglio et al. J Infect. 2022 Jun.
No abstract available

Keywords: Omicron; Public health; SARS-CoV-2; Statistical model.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no conflict of interest to declare.

Figures

Fig. 1.
Fig. 1.
Daily dynamics of SARS-CoV-2 infection, July 21, 2020 to February 21, 2022. A. Assuming that the Omicron BA.1 sub-variant is as sensitive as Delta to vaccination/previous immunity. B. Assuming that the Omicron BA.2 sub-variant is as sensitive as BA.1 to vaccination/previous immunity. C. Real daily dynamics of SARS-CoV-2 infection, July 21, 2020 to February 21, 2022.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

References

    1. Kuhlmann C., Mayer C.K., Claassen M., Maponga T., Burgers W.A., Keeton R., Riou C., Sutherland A.D., Suliman T., Shaw M.L., Preiser W. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose. Lancet. 2022 Feb 12;399(10325):625–626. doi: 10.1016/S0140-6736(22)00090-3. - DOI - PMC - PubMed
    1. Dimeglio C., Milhes M., Loubes J.M., Ranger N., Mansuy J.M., Trémeaux P., Jeanne N., Latour J., Nicot F., Donnadieu C., Izopet J. Influence of SARS-CoV-2 variant B.1.1.7, vaccination, and public health measures on the spread of SARS-CoV-2. Viruses. 2021 May 12;13(5):898. doi: 10.3390/v13050898. - DOI - PMC - PubMed
    1. Dimeglio C., Loubes J.M., Mansuy J.M., Izopet J. Quantifying the impact of public health protection measures on the spread of SARS-CoV-2. J Infect. 2020 - PMC - PubMed
    1. Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F., Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T., Morgan O., le Polain de Waroux O. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill. 2021;26(24) doi: 10.2807/1560-7917.ES.2021.26.24.2100509. - DOI - PMC - PubMed
    1. Burki T.K. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022;10(2):e17. doi: 10.1016/S2213-2600(21)00559-2. - DOI - PMC - PubMed